LONDON, Jan. 7, 2022 /PRNewswire/ — NEXTYPE, an integrated blockchain game distribution platform, announced that it has listed its NT token on Huobi Global, one of the world’s leading digital asset exchanges. As a blockchain Read more…
SUZHOU, China, Jan. 7, 2022 /PRNewswire/ — The “first meeting of the New Year” was held in Suzhou, China on January 5, announcing that the regional GDP of 2.2 trillion yuan was expected to be Read more…
US equities, cryptocurrencies, and precious metals declined on Thursday as investors started to adjust for the upcoming interest rate hikes. The Dow Jones declined by about 170 points while the Nasdaq 100 and S&P 500 Read more…
DALLAS, Jan. 7, 2022 /PRNewswire/ — The transformative book “The Rise of the Prophetic Voice” has crossed more than 3 million copies in sales worldwide, as per AMI USA. The book is said to have Read more…
SHANGHAI, Jan. 7, 2022 /PRNewswire/ — Daqo New Energy Corp. (DQ) – Get Daqo New Energy Corp. Report (“Daqo New Energy”, the “Company” or “we”), a leading manufacturer of high-purity polysilicon for the global solar PV Read more…
EUR/USD Current level – 1.1295 The market continues to trade without a clear direction and, at the time of writing this analysis, the single European currency is on the verge of testing the support zone Read more…
BANGKOK, Jan. 7, 2022 /PRNewswire/ — A dazzling showcase of 30,000 eco-friendly firework lighting up the sky over a 1,400-metre stretch of Thailand’s majestic Chao Phraya River serves ICONSIAM as one of the iconic global countdown Read more…
Markets December FOMC Minutes still echoed through dealing rooms yesterday. Markets concluded that the US central bank could be on its way for a March rate hike with intentions to start winding down the $8.8tn Read more…
SHANGHAI, Jan. 7, 2022 /PRNewswire/ — Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce the promotions of Bonnie Wang and Dr. Kan Chen to Partner, and Xiaofei Zhou to Read more…
ZURICH, Jan. 7, 2022 /PRNewswire/ — Neurimmune AG today announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s Rare Disease group, to develop NI006, an investigational human monoclonal antibody Read more…